In MYCN-amplified neuroblastoma, THZ1 treatment led to preferential downregulation of SE-associated genes, including MYCN, thus inhibiting the autoregulated suppression of MYCN-driven global transcription amplification23. Here, MYCN is linked to neuroblastoma.